Jpmorgan Chase & CO Enovis Corp Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ENOV
# of Institutions
310Shares Held
60.2MCall Options Held
1.68MPut Options Held
693K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.63MShares$295 Million0.17% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$242 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$241 Million0.0% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH3MShares$134 Million0.54% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.99MShares$133 Million0.03% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.41B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...